Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Enterprise Value

Arbutus Biopharma Cp Enterprise Value Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Enterprise Value from 2010 to 2018.
  • Arbutus Biopharma Cp Enterprise Value for the quarter ending March 03, 2018 was $211m a 52.69% increase of 111m year over year
  • Arbutus Biopharma Cp Annual Enterprise Value for 2017 was $202m a 107.59% increase of 217m from 2016
  • Arbutus Biopharma Cp Annual Enterprise Value for 2016 was $-15m a 405.09% decrease of -62m from 2015
  • Arbutus Biopharma Cp Annual Enterprise Value for 2015 was $47m a -390.58% decrease of -183m from 2014
Other Valuation Metrics:
  • Arbutus Biopharma Cp Market Cap for the quarter ending March 03, 2018 was $275m a 28.06% increase of 77m year over year
  • Arbutus Biopharma Cp Price / Book for the quarter ending March 03, 2018 was 2.07 a 49.51% increase of 1.03 year over year
View Chart On Koyfin

Quarterly ABUS Enterprise Value Data

03/2018$211m
12/2017$202m
09/2017$250m
06/2017$100m
03/2017$60m
12/2016$-15m
09/2016$23m
06/2016$18m
03/2016$44m
12/2015$47m

Annual ABUS Enterprise Value Data

2017$202m
2016$-15m
2015$47m
2014$229m
2013$116m
2012$64m
2011$9m
2010$33m